Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the website transition and its terminology update has been added, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:19:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-06T19:26:24.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record, replacing detailed trial information with a generic error page and a Home link.
    Difference
    19%
    Check dated 2026-09-22T22:09:03.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s revision indicator was updated from v3.6.6 to v3.7.0, signaling a frontend/software update. The study details and related information remain the same.
    Difference
    0.1%
    Check dated 2026-09-15T20:30:50.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the site version. This change does not modify study details, eligibility, locations, or participant information.
    Difference
    0.1%
    Check dated 2026-09-01T17:46:37.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.6.4 to v3.6.5 on the study page, signaling a new version of the page. This appears to be routine maintenance rather than a change to study details or core information.
    Difference
    0.1%
    Check dated 2026-08-11T22:08:59.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.